US Patent 6846810 Antiviral nucleoside derivatives
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 14 Oct, 2023
Golden AI
Edits made to:
Infobox (+12 properties)
Article (+508 characters)
Article
Patent abstract
The present invention relates to nucleoside derivatives for the treatment of Hepatitis C viral infections including compounds of formula I, pharmaceutical compositions comprising these compounds and methods for treatment or prophylaxis of Hepatitis C Virus mediated diseases employing said compounds in monotherapy or in combination therapy. The present invention further provides a process for preparing 1′,3′,4′-triacyl pyrimidine nucleoside from a N, 1′,3′,4′-tetraacylpyrimidine nucleoside
Infobox
Is a
Patent Applicant
0
Patent Jurisdiction
Patent Number
Patent Inventor Names
David Bernard Smith0
Joseph Armstrong Martin0
Keshab Sarma0
Mark Smith0
Date of Patent
January 25, 2005
0Patent Application Number
107172600
Date Filed
November 19, 2003
0Patent Primary Examiner
Edits on 12 Oct, 2023
Golden AI
Edits made to:
US Patent 6846810 Antiviral nucleoside derivatives
Find more entities like US Patent 6846810 Antiviral nucleoside derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.